reports
- Daniel Appiah
SourceBio reinvesting for post-Covid business
SourceBio International PLC (Source), a UK-based company, provides clinical and drug development laboratory services to blue-chip pharmaceutical companies, the NHS and private clinics. Source operates three core business units: healthcare diagnostics, genomics, and stability storage, and has a non-
- Emma Ulker
SourceBio International: Back with a Bang
SourceBio International (SBI) has made a huge impact on its return to public markets. It reported a 139% rise in fiscal 2020 (FY20) reported revenues to £50.7mln from £21.2mln and underlying earnings (EBITDA) of £14mln, vs £3mln in FY19. Growth was driven largely on its rapid mobilisation of resour
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.